All articles by Matt Wilkinson – Page 3
-
News
£250m to train new breed of UK scientists
EPSRC outlines details of multidisciplinary centres for 2,000 PhD students
-
News
EU claims pharma delaying tactics cost 3 billion euro
Commission report raps industry for stalling generic competition.
-
News
Depressing failure for obesity target
Four pharmaceutical firms have halted research into obesity drugs from a class that was once expected to generate billions of dollars in sales
-
News
Rocks to soak up carbon dioxide
Peridotite could mop up billions of tons of carbon dioxide a year, study estimates
-
News
GSK snaps up Hepatitis drug developer
GSK is back on the acquisition trail with the purchase of hepatitis therapy experts Genelabs
-
News
Europe suspends antiobesity drug
EMEA has recommended that doctors stop prescribing Sanofi-aventis' anti-obesity drug rimonabant
-
News
Merck to slash more jobs
Merck is slashing more than 10 per cent of its workforce as it tries to increase efficiency.
- Previous Page
- Page1
- Page2
- Page3
- Next Page